Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.
How long patients survive after surgery to remove lung cancer may depend on factors like insurance, income and education, according to a new study.
AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
The U.S. Food and Drug Administration said on Friday it has approved Japanese pharmaceutical company Eisai's drug Akynzeo to treat nausea and vomiting in patients undergoing chemotherapy for cancer.
U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.
AstraZeneca's MedImmune unit has partnered with Immunocore, a private British biotechnology company, to develop a cancer drug that would tap on the body's immune system, Reuters reported.
USD9 million was raised in Series A funding round for ImmunGene Inc.
immatics raises EUR34 million in its latest Series D round financing.
Subscribe to VCpost newsletter
Most Popular
- Neuralink Co-Founder Implies He Left Elon Musk's Brain Implant Company Over Safety Concerns
- Tennessee Cleaning Company Fined $650,000 for Illegally Hiring Children, Some as Young as 13, to Clean Dangerous Slaughterhouses
- New York Is the World's Richest City, With Its Millionaires and Billionaires' Wealth Greater Than GDPs of Brazil, Canada, Italy
- Mini Gold Bars Are Causing a Frenzy in South Korea as Buyers Rush to Get Them in Convenience Stores, Vending Machines
- AstraZeneca to Pull Out COVID-19 Vaccine Worldwide After Adverse Side Effect Admission
- Joe Biden Administration Sanctions Colombian Maritime Companies Preying on Vulnerable Migrants Seeking to Enter US
- Pfizer Settles 10,000 Zantac Heartburn Medication Lawsuits Over Cancer Risks
- Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout